SNOA logo

Sonoma Pharmaceuticals (SNOA) Selling, General & Administrative Expenses

Annual SGA

$7.58 M
-$1.26 M-14.31%

March 31, 2024

Summary

Performance

1-Year Change

-14.31%

3-Year Change

-19.87%

5-Year Change

-59.32%

15-Year Change

-55.61%

SNOA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.29%
SNOA annual SGA is higher than 16.29% of companies in Healthcare sector

High & Low

All-time High

$19.92 M
SNOA annual SGA is currently -61.98% below its historical high of $19.92 million

3-Year Low

$7.58 M
SNOA annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
SNOA previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
SNOA next annual earnings announcement has not yet been scheduled

OtherSNOAexpensesmetrics:

Annual Total Expenses

$17.44 M
SNOA annual total expenses is $17.44 million

Annual Operating Expenses

$9.45 M
SNOA annual total operating expenses is $9.45 million

Annual Cost Of Goods Sold

$7.99 M
SNOA annual cost of goods sold is $7.99 million

Annual Interest Expense

-
SNOA annual interest expense value is unknown

Quarterly SGA

$1.87 M
+$169.00 K+9.91%

December 31, 2024

Summary

Performance

3-Month Change

+9.91%

1-Year Change

+10.04%

3-Year Change

+3.54%

5-Year Change

+3.54%

SNOA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.31%
SNOA quarterly SGA is higher than 16.31% of companies in Healthcare sector

High & Low

All-time High

$5.61 M
SNOA quarterly SGA is currently -66.57% below its historical high of $5.61 million

3-Year Low

$1.66 M
SNOA quarterly SGA is currently +12.76% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SNOA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
SNOA next earnings announcement is scheduled for Feb 7, 2025

OtherSNOAexpensesmetrics:

Quarterly Total Expenses

$4.59 M
SNOA quarterly total expenses is $4.59 million

Quarterly Operating Expenses

$2.30 M
SNOA quarterly total operating expenses is $2.30 million

Quarterly Cost Of Goods Sold

$2.29 M
SNOA quarterly cost of goods sold is $2.29 million

Quarterly Interest Expense

-
SNOA quarterly interest expense value is unknown

TTM SGA

-$782.97 M
-$3.75 M-0.48%

December 31, 2024

Summary

Performance

3-Month Change

-10528.52%

1-Year Change

-10834.48%

3-Year Change

-8960.17%

5-Year Change

-8960.17%

SNOA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.03%
SNOA TTM SGA is higher than 51.03% of companies in Healthcare sector

High & Low

All-time High

-$27.08 M

3-Year Low

-$782.97 M
SNOA TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
SNOA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
SNOA next earnings announcement is scheduled for Feb 7, 2025

OtherSNOAexpensesmetrics:

Annual Total Expenses

$17.44 M
SNOA annual total expenses is $17.44 million

Annual Operating Expenses

$9.45 M
SNOA annual total operating expenses is $9.45 million

TTM Cost Of Goods Sold

$8.95 M
SNOA TTM cost of goods sold is $8.95 million

TTM Interest Expense

-
SNOA TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$7.58 M
SNOA annual SGA is $7.58 million

Annual Operating Expenses

$9.45 M
SNOA annual total operating expenses is $9.45 million

Annual Cost Of Goods Sold

$7.99 M
SNOA annual cost of goods sold is $7.99 million

SNOA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.3%+10.0%-10000.0%
3 y3 years-19.9%+3.5%-8960.2%
5 y5 years-59.3%+3.5%-8960.2%

SNOA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.4%at low-40.5%+12.8%-8.5%at low
5 y5-year-59.3%at low-57.4%+12.8%-15.4%at low
alltimeall time-62.0%+471.3%-66.6%+12.8%-2791.3%at low

Sonoma Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
-
$1.87 M(+9.9%)
$7.68 M(+2.3%)
Sep 2024
-
$1.71 M(-15.1%)
$7.51 M(+0.6%)
Jun 2024
-
$2.01 M(-3.9%)
$7.46 M(-1.5%)
Mar 2024
$7.58 M(-14.3%)
$2.09 M(+22.8%)
$7.58 M(+3.9%)
Dec 2023
-
$1.70 M(+2.5%)
$7.29 M(-11.7%)
Sep 2023
-
$1.66 M(-21.6%)
$8.26 M(-4.7%)
Jun 2023
-
$2.12 M(+17.1%)
$8.66 M(-2.0%)
Mar 2023
$8.84 M(-9.4%)
$1.81 M(-32.1%)
$8.84 M(-13.2%)
Dec 2022
-
$2.67 M(+28.9%)
$10.18 M(+5.5%)
Sep 2022
-
$2.07 M(-9.9%)
$9.65 M(-1.3%)
Jun 2022
-
$2.29 M(-27.2%)
$9.78 M(+0.2%)
Mar 2022
$9.76 M(+3.2%)
$3.15 M(+47.6%)
$9.76 M(+7.3%)
Dec 2021
-
$2.13 M(-2.7%)
$9.09 M(+0.4%)
Sep 2021
-
$2.19 M(-3.4%)
$9.06 M(-2.4%)
Jun 2021
-
$2.27 M(-8.7%)
$9.28 M(-1.8%)
Mar 2021
$9.45 M(-33.3%)
$2.49 M(+18.6%)
$9.45 M(-16.8%)
Dec 2020
-
$2.10 M(-13.2%)
$11.36 M(-6.3%)
Sep 2020
-
$2.42 M(-1.1%)
$12.12 M(-6.0%)
Jun 2020
-
$2.44 M(-44.4%)
$12.89 M(-9.0%)
Mar 2020
$14.17 M(-23.9%)
$4.39 M(+53.6%)
$14.17 M(+1.0%)
Dec 2019
-
$2.86 M(-10.4%)
$14.03 M(-11.8%)
Sep 2019
-
$3.19 M(-14.3%)
$15.92 M(-8.6%)
Jun 2019
-
$3.73 M(-12.4%)
$17.41 M(-6.5%)
Mar 2019
$18.62 M(-6.5%)
$4.25 M(-10.4%)
$18.62 M(-6.8%)
Dec 2018
-
$4.75 M(+1.2%)
$19.97 M(-2.3%)
Sep 2018
-
$4.69 M(-4.9%)
$20.45 M(+1.8%)
Jun 2018
-
$4.93 M(-12.0%)
$20.09 M(+0.9%)
Mar 2018
$19.92 M(+16.7%)
$5.61 M(+7.4%)
$19.92 M(+5.8%)
Dec 2017
-
$5.22 M(+20.3%)
$18.83 M(+2.4%)
Sep 2017
-
$4.34 M(-8.9%)
$18.39 M(+3.9%)
Jun 2017
-
$4.76 M(+5.6%)
$17.70 M(+3.7%)
Mar 2017
$17.07 M(+9.7%)
$4.51 M(-5.7%)
$17.07 M(+2.2%)
Dec 2016
-
$4.78 M(+31.3%)
$16.70 M(+3.9%)
Sep 2016
-
$3.64 M(-11.8%)
$16.08 M(+0.7%)
Jun 2016
-
$4.13 M(-0.4%)
$15.97 M(+2.7%)
Mar 2016
$15.56 M(+25.3%)
$4.14 M(-0.3%)
$15.56 M(+5.9%)
Dec 2015
-
$4.16 M(+17.6%)
$14.68 M(+6.7%)
Sep 2015
-
$3.54 M(-4.9%)
$13.76 M(+4.7%)
Jun 2015
-
$3.72 M(+13.6%)
$13.15 M(+5.9%)
DateAnnualQuarterlyTTM
Mar 2015
$12.41 M(+7.4%)
$3.27 M(+1.1%)
$12.41 M(+4.2%)
Dec 2014
-
$3.24 M(+10.8%)
$11.91 M(+3.1%)
Sep 2014
-
$2.92 M(-1.9%)
$11.55 M(-1.5%)
Jun 2014
-
$2.98 M(+7.7%)
$11.72 M(+1.4%)
Mar 2014
$11.56 M(-2.8%)
$2.77 M(-3.9%)
$11.56 M(-1.1%)
Dec 2013
-
$2.88 M(-6.9%)
$11.69 M(+2.1%)
Sep 2013
-
$3.09 M(+9.7%)
$11.46 M(-3.5%)
Jun 2013
-
$2.82 M(-2.8%)
$11.87 M(-0.2%)
Mar 2013
$11.89 M(-9.9%)
$2.90 M(+9.8%)
$11.89 M(-1.8%)
Dec 2012
-
$2.64 M(-24.6%)
$12.12 M(-8.0%)
Sep 2012
-
$3.50 M(+23.1%)
$13.17 M(+5.2%)
Jun 2012
-
$2.85 M(-8.9%)
$12.52 M(-5.2%)
Mar 2012
$13.20 M(+13.8%)
$3.12 M(-15.5%)
$13.20 M(+3.4%)
Dec 2011
-
$3.70 M(+29.8%)
$12.76 M(+7.9%)
Sep 2011
-
$2.85 M(-19.3%)
$11.82 M(+0.7%)
Jun 2011
-
$3.53 M(+31.5%)
$11.74 M(+1.2%)
Mar 2011
$11.60 M(+17.2%)
$2.69 M(-2.7%)
$11.60 M(+2.5%)
Dec 2010
-
$2.76 M(-0.2%)
$11.32 M(+4.0%)
Sep 2010
-
$2.77 M(-18.4%)
$10.88 M(+2.6%)
Jun 2010
-
$3.39 M(+41.0%)
$10.60 M(+7.1%)
Mar 2010
$9.90 M(-28.6%)
$2.40 M(+3.4%)
$9.90 M(+0.6%)
Dec 2009
-
$2.32 M(-6.5%)
$9.84 M(-5.7%)
Sep 2009
-
$2.48 M(-7.4%)
$10.44 M(-21.0%)
Jun 2009
-
$2.69 M(+14.4%)
$13.21 M(-4.6%)
Mar 2009
$13.86 M(+0.9%)
$2.35 M(-19.6%)
$13.86 M(-6.4%)
Dec 2008
-
$2.92 M(-44.5%)
$14.80 M(-2.5%)
Sep 2008
-
$5.26 M(+58.1%)
$15.18 M(+11.6%)
Jun 2008
-
$3.33 M(+1.1%)
$13.60 M(-0.9%)
Mar 2008
$13.73 M(-16.9%)
$3.29 M(-0.2%)
$13.73 M(-5.2%)
Dec 2007
-
$3.30 M(-10.4%)
$14.48 M(-8.3%)
Sep 2007
-
$3.68 M(+6.5%)
$15.79 M(-3.3%)
Jun 2007
-
$3.46 M(-14.4%)
$16.33 M(+26.9%)
Mar 2007
$16.52 M(+3.7%)
$4.04 M(-12.4%)
$12.88 M(+45.7%)
Dec 2006
-
$4.61 M(+9.3%)
$8.84 M(+109.3%)
Sep 2006
-
$4.22 M
$4.22 M
Mar 2006
$15.93 M(+27.5%)
-
-
Mar 2005
$12.49 M(+494.3%)
-
-
Mar 2003
$2.10 M(+58.5%)
-
-
Mar 2002
$1.33 M
-
-

FAQ

  • What is Sonoma Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals annual SGA year-on-year change?
  • What is Sonoma Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals quarterly SGA year-on-year change?
  • What is Sonoma Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals TTM SGA year-on-year change?

What is Sonoma Pharmaceuticals annual SGA?

The current annual SGA of SNOA is $7.58 M

What is the all time high annual SGA for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high annual SGA is $19.92 M

What is Sonoma Pharmaceuticals annual SGA year-on-year change?

Over the past year, SNOA annual SGA has changed by -$1.26 M (-14.31%)

What is Sonoma Pharmaceuticals quarterly SGA?

The current quarterly SGA of SNOA is $1.87 M

What is the all time high quarterly SGA for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high quarterly SGA is $5.61 M

What is Sonoma Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, SNOA quarterly SGA has changed by +$171.00 K (+10.04%)

What is Sonoma Pharmaceuticals TTM SGA?

The current TTM SGA of SNOA is -$782.97 M

What is the all time high TTM SGA for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high TTM SGA is -$27.08 M

What is Sonoma Pharmaceuticals TTM SGA year-on-year change?

Over the past year, SNOA TTM SGA has changed by -$790.27 M (-10834.48%)